Myelosuppression Alleviation and Hematopoietic Regeneration by Tetrahedral‐Framework Nucleic‐Acid Nanostructures Functionalized with Osteogenic Growth Peptide
Source abstract
Abstract
Abstract As major complications of chemoradiotherapy, myelosuppression and hematopoietic‐system damage severely affect immunologic function and can delay or even terminate treatment for cancer patients. Although several specific cytokines have been used for hematopoiesis recovery, their effect is limited, and they may increase the risk of tumor recurrence. In this study, osteogenic growth peptide functionalized tetrahedral framework nucleic‐acid nanostructures (OGP‐tFNAs) are prepared; they combine the positive hematopoiesis stimulating effect of OGP and the drug carrying function of tFNAs. The potential of OGP‐tFNAs for hematopoietic stimulation and microenvironment regulation is investigated. It is shown that OGP‐tFNAs can protect bone marrow stromal cells from 5‐fluorouracil (5‐FU)‐induced DNA damage and apoptosis. OGP‐tFNAs pretreatment activates the extracellularly regulated protein kinase signal and downregulates apoptosis‐related proteins. OGP‐tFNAs also alleviate the chemotherapy‐induced inhibition of hematopoiesis‐related cytokine expression, which is crucial for hematopoiesis reconstitution. In conclusion, OGP‐tFNAs can protect hematopoietic cells and their microenvironment from chemotherapy‐induced injuries and myelosuppression, while promoting hematopoiesis regeneration.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · Acute Myeloid Leukemia Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Oral Diseases National Clinical Research Center for Oral Diseases West China Hospital of Stomatology Sichuan University Chengdu 610041 P. R. China
Department of Oral and Maxillofacial Surgery The Affiliated Stomatology Hospital of Southwest Medical University Luzhou 646000 P. R. China
Funding
National Natural Science Foundation of China · Sichuan Province Youth Science and Technology Innovation Team
References (90)
Show source-provided references
1. 10.1007/s12325-020-01419-610.1007/s12325-020-01419-6 ↗
2. 10.1177/247255521877796810.1177/2472555218777968 ↗
3. 10.1080/13696998.2021.202057010.1080/13696998.2021.2020570 ↗
4. 10.1182/bloodadvances.201900013310.1182/bloodadvances.2019000133 ↗
5. 10.1016/S1470-2045(21)00650-110.1016/S1470-2045(21)00650-1 ↗
6. 10.1097/MD.000000000002430710.1097/MD.0000000000024307 ↗
7. 10.7150/thno.6942410.7150/thno.69424 ↗
8. 10.7150/thno.5782810.7150/thno.57828 ↗
9. 10.1016/j.ijpharm.2021.12043810.1016/j.ijpharm.2021.120438 ↗
10. 10.1016/j.addr.2017.06.00410.1016/j.addr.2017.06.004 ↗
11. 10.1038/s41375-020-01062-810.1038/s41375-020-01062-8 ↗
12. 10.1038/nri.2017.5310.1038/nri.2017.53 ↗
13. 10.1016/j.devcel.2021.05.01810.1016/j.devcel.2021.05.018 ↗
14. 10.1016/j.actbio.2021.03.06110.1016/j.actbio.2021.03.061 ↗
15. 10.3389/fimmu.2021.79037910.3389/fimmu.2021.790379 ↗
16. 10.1016/j.addr.2021.11406910.1016/j.addr.2021.114069 ↗
17. 10.3109/1042819010909770510.3109/10428190109097705 ↗
18. 10.1001/jamanetworkopen.2021.3347410.1001/jamanetworkopen.2021.33474 ↗
19. 10.1038/s41419-020-2276-810.1038/s41419-020-2276-8 ↗
20. 10.1111/nyas.1416910.1111/nyas.14169 ↗
21. 10.1158/1535-7163.MCT-15-077510.1158/1535-7163.MCT-15-0775 ↗
22. 10.1667/RADE-21-00169.110.1667/RADE-21-00169.1 ↗
23. 10.1158/0008-5472.CAN-06-015810.1158/0008-5472.CAN-06-0158 ↗
24. 10.3390/cancers1210286810.3390/cancers12102868 ↗
25. 10.1002/adhm.20180115810.1002/adhm.201801158 ↗
26. 10.1021/acs.chemrev.7b0066310.1021/acs.chemrev.7b00663 ↗
27. 10.1016/j.jconrel.2020.03.04010.1016/j.jconrel.2020.03.040 ↗
28. 10.1002/anie.20190992710.1002/anie.201909927 ↗
29. 10.1002/advs.20200377510.1002/advs.202003775 ↗
30. 10.1021/acs.chemrev.6b0082510.1021/acs.chemrev.6b00825 ↗
31. 10.1038/nature0458610.1038/nature04586 ↗
32. 10.1021/acssensors.8b0025710.1021/acssensors.8b00257 ↗
33. 10.1002/advs.20210021610.1002/advs.202100216 ↗
34. 10.1002/adma.20180478510.1002/adma.201804785 ↗
35. 10.1002/adfm.20210972810.1002/adfm.202109728 ↗
36. Zhang T. · Adv. Mater. · 2021
37. 10.1038/s41596-020-0355-z10.1038/s41596-020-0355-z ↗
38. 10.1016/j.mattod.2018.08.00210.1016/j.mattod.2018.08.002 ↗
39. 10.1002/adma.20210960910.1002/adma.202109609 ↗
40. 10.1016/j.cej.2022.13485510.1016/j.cej.2022.134855 ↗
41. 10.1016/j.bioactmat.2021.11.03110.1016/j.bioactmat.2021.11.031 ↗
42. 10.1021/acsnano.1c0962610.1021/acsnano.1c09626 ↗
43. 10.1038/s41392-021-00727-910.1038/s41392-021-00727-9 ↗
44. 10.1021/acs.nanolett.1c0500310.1021/acs.nanolett.1c05003 ↗
45. 10.1016/j.ijbiomac.2021.01.15210.1016/j.ijbiomac.2021.01.152 ↗
46. 10.1002/smll.20200216210.1002/smll.202002162 ↗
47. 10.1021/acs.accounts.7b0005110.1021/acs.accounts.7b00051 ↗
48. 10.1016/j.tibtech.2020.02.00710.1016/j.tibtech.2020.02.007 ↗
49. 10.1016/j.bone.2004.03.02510.1016/j.bone.2004.03.025 ↗
50. 10.1002/bip.1020210.1002/bip.10202 ↗
51. 10.1182/blood.V88.12.4719.bloodjournal8812471910.1182/blood.V88.12.4719.bloodjournal88124719 ↗
52. 10.1016/S0145-2126(01)00091-110.1016/S0145-2126(01)00091-1 ↗
53. 10.1038/s41467-018-06979-410.1038/s41467-018-06979-4 ↗
54. 10.1016/j.biomaterials.2013.07.10210.1016/j.biomaterials.2013.07.102 ↗
55. 10.1038/s41467-019-12470-510.1038/s41467-019-12470-5 ↗
56. 10.1016/j.actbio.2021.05.01910.1016/j.actbio.2021.05.019 ↗
57. 10.2217/nnm.15.18810.2217/nnm.15.188 ↗
58. 10.1016/j.jconrel.2016.01.04110.1016/j.jconrel.2016.01.041 ↗
59. 10.1016/j.it.2013.10.00210.1016/j.it.2013.10.002 ↗
60. 10.1016/j.biomaterials.2022.12156710.1016/j.biomaterials.2022.121567 ↗
61. 10.1021/acs.nanolett.2c0053710.1021/acs.nanolett.2c00537 ↗
62. 10.1021/acsami.1c2065710.1021/acsami.1c20657 ↗
63. 10.1021/acsami.9b1907910.1021/acsami.9b19079 ↗
64. 10.1016/j.bioactmat.2021.07.02810.1016/j.bioactmat.2021.07.028 ↗
65. 10.1016/0167-4889(93)90204-310.1016/0167-4889(93)90204-3 ↗
66. 10.1038/sj.cr.729010510.1038/sj.cr.7290105 ↗
67. 10.1158/1078-0432.CCR-18-252310.1158/1078-0432.CCR-18-2523 ↗
68. 10.3390/ijms1811226510.3390/ijms18112265 ↗
69. 10.1053/j.seminhematol.2007.04.00610.1053/j.seminhematol.2007.04.006 ↗
70. 10.1038/s41586-021-03298-510.1038/s41586-021-03298-5 ↗
71. 10.1016/j.ijbiomac.2020.05.04510.1016/j.ijbiomac.2020.05.045 ↗
72. 10.1016/j.stem.2018.11.02210.1016/j.stem.2018.11.022 ↗
73. 10.1038/ncb357010.1038/ncb3570 ↗
74. 10.1073/pnas.91.6.230510.1073/pnas.91.6.2305 ↗
75. 10.1038/382635a010.1038/382635a0 ↗
76. 10.1016/j.immuni.2006.10.01610.1016/j.immuni.2006.10.016 ↗
77. Schofield R. · Blood Cells · 1978 · 4 · 7
78. 10.1038/nm.211910.1038/nm.2119 ↗
79. 10.1016/j.stem.2018.07.00310.1016/j.stem.2018.07.003 ↗
80. 10.1007/s10565-019-09510-710.1007/s10565-019-09510-7 ↗
81. 10.1002/bies.20170019010.1002/bies.201700190 ↗
82. 10.3389/fgene.2021.59885510.3389/fgene.2021.598855 ↗
83. 10.1016/j.stem.2020.06.00310.1016/j.stem.2020.06.003 ↗
84. 10.1016/j.celrep.2021.11003610.1016/j.celrep.2021.110036 ↗
85. 10.1084/jem.174.1.6310.1084/jem.174.1.63 ↗
86. 10.1182/blood.202000787610.1182/blood.2020007876 ↗
87. 10.1016/j.stemcr.2017.04.01210.1016/j.stemcr.2017.04.012 ↗
88. Yue Z. · J. Clin. Rehabil. Tissue Eng. Res. · 2010 · 14 · 6015
89. 10.1182/blood-2002-06-191810.1182/blood-2002-06-1918 ↗
90. 10.1038/s41467-021-27263-y10.1038/s41467-021-27263-y ↗